MarketWatch: START Partners with Trialing to Expand Access to Oncology Clinical Trials Across Europe
START Partners with Trialing to Expand Access to Oncology Clinical Trials Across Europe
Yahoo: Rush announces major donation to help it dramatically expand clinical trials for cancer patients
Add Yahoo as a preferred source to see more of our stories on Google. Rush University System for Health plans to dramatically expand its clinical trials for patients with cancer thanks to a major ...
Rush announces major donation to help it dramatically expand clinical trials for cancer patients
News Medical: City of Hope launches innovative national clinical trials model to expand access to cancer treatments
City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S., launched an innovative national clinical trials model to expand access to emerging ...
City of Hope launches innovative national clinical trials model to expand access to cancer treatments
Knoxville News Sentinel: Trial Library Raises $10 Million Series A to Expand Access to Clinical Trials as a Care Option
Trial Library Raises $10 Million Series A to Expand Access to Clinical Trials as a Care Option
Clinical research organization Icon has entered into a partnership with research technology company Advarra to launch a network of connected sites for clinical trials. The partnership will combine ...
Morningstar: Bio Behavioral Health Joins PhaseWell Research to Expand Access to Neuropsychiatric Clinical Trials
Bio Behavioral Health Joins PhaseWell Research to Expand Access to Neuropsychiatric Clinical Trials
MSN: Eli Lilly, IU agree to $40 million agreement to expand clinical trials
Eli Lilly and Indiana University signed a $40 million research agreement on Dec. 3 that will beef up the availability and accessibility of clinical trials in Indiana. Under the agreement, Lilly will ...
Eli Lilly, IU agree to $40 million agreement to expand clinical trials
Chicago Tribune: Rush announces major donation to help it dramatically expand clinical trials for cancer patients
Rush University System for Health plans to dramatically expand its clinical trials for patients with cancer thanks to a major donation from the family foundation of late business leader Harold B.
The mission of the WHO International Clinical Trials Registry Platform is to ensure that a complete view of research is accessible to all those involved in health care decision making. This will improve research transparency and will ultimately strengthen the validity and value of the scientific evidence base.
MarketWatch: Lightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research Delivery
Morningstar: Slope and LabConnect Expand Partnership Momentum with Multiple API-Integrated Clinical Trials Launched in Q4 2025
Slope and LabConnect Expand Partnership Momentum with Multiple API-Integrated Clinical Trials Launched in Q4 2025
Opaganib has demonstrated its safety and tolerability profile in more than 470 people in multiple clinical studies and expanded access use. Data from the opaganib global Phase 2/3 study was published in Microorganisms.
The MarketWatch News Department was not involved in the creation of this content. Partnership will enhance physician awareness of START's portfolio of trials, streamline referrals, and support patient ...
Yahoo Finance: Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities
Yahoo Finance: IXICO boss on 'tech bio' deal that creates solution for clinical trials - ICYMI
IXICO boss on 'tech bio' deal that creates solution for clinical trials - ICYMI
Business Insider: Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication
Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication
MSN: Biorce secures $52.5m in Series A to expand AI clinical trial tech
Biorce secures $52.5m in Series A to expand AI clinical trial tech
Morningstar: Previvor Edge Expands Platform to Deliver Personalized Clinical-Grade Cancer Risk Profiles and Interactive Prevention Plans
Previvor Edge Expands Platform to Deliver Personalized Clinical-Grade Cancer Risk Profiles and Interactive Prevention Plans
Clinical trials are a type of research that studies new tests and treatments and evaluates their effects on human health outcomes.
Join WHO for the launch of the free, online, self-paced ‘WHO Good Practices for Clinical Trial Design and Implementation’ course and #StandWithScience in 2026.The course is designed for learners with little or no hands-on experience in conducting clinical trials, though a basic theoretical understanding of standard trial designs and key research concepts is assumed.
Some of the world’s largest funders of medical research have today committed, through the signature of a joint statement, to implement WHO standards to strengthen clinical trial systems and ensure that research better serves patients and communities. The statement sets out measures to integrate clinical trials into sustainable national infrastructure, improve trial design, ensure that trial ...
This guidance updates and adapts the previous work of the World Health Organization (WHO) on research capacity for the context of well-designed and well-implemented clinical trials as framed in resolution WHA75.8 (2022). It aims to enhance clinical research efficiency, minimize research waste and provide guidance on sustained clinical trials that are always functional and active for endemic ...
In September 2024, the World Health Organization (WHO) launched its landmark publication "Guidance for best practices for clinical trials". This pivotal document is described as "not an endpoint but a starting point" (1) for enhancing global health through robust, ethical, and inclusive clinical research. It serves as a foundational resource aimed at improving the design, conduct, and ...
A starting point, not an endpoint: WHO's new clinical trials guidance ...
WHO has today launched the Global Clinical Trials Forum (GCTF), a global, multi-stakeholder network to strengthen clinical trial environments and infrastructure at national, regional and global levels.
API integration drives adoption among multiple sponsors, unifying data exchange across the biospecimen lifecycle for complex clinical trials. RICHMOND, Va. and RALEIGH, N.C., Jan. 29, 2026 /PRNewswire ...
RedHill's key clinical late-stage development programs include: (i) opaganib (ABC294640), a first-in-class, orally administered sphingosine kinase-2 (SPHK2) selective inhibitor with anti-inflammatory, antiviral, and anticancer activity, targeting multiple indications with U.S. government and academic collaborations for development for radiation ...